Cell Therapies
- 1 June 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 44 (6_suppl_1), S107-9
- https://doi.org/10.1161/strokeaha.112.679605
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Determination of the Therapeutic Time Window for Human Umbilical Cord Blood Mononuclear Cell Transplantation following Experimental Stroke in RatsCell Transplantation, 2012
- Nitric Oxide Facilitates Delivery and Mediates Improved Outcome of Autologous Bone Marrow Mononuclear Cells in a Rodent Stroke ModelPLOS ONE, 2012
- Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic StrokeCell Transplantation, 2012
- Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke ModelTranslational Stroke Research, 2011
- Intravenous autologous bone marrow mononuclear cells for ischemic strokeAnnals of Neurology, 2011
- Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemiaBrain Research, 2010
- Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinicThe Lancet Neurology, 2009
- Themes and Strategies for Studying the Biology of Stroke Recovery in the Poststroke EpochStroke, 2008
- Behavioral alterations in lewis rats following two-day continuous 3-nitropropionic acid administrationNeurotoxicity Research, 2005
- A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult ratsBrain Research, 2004